Anti-arrhythmic pharmaceutical composition and a process thereof
AssigneeCouncil of Scientific and Industrial Research
InventorsAntony Gomes, Archita Saha, Ajoy Kumar Biswas, Subir Chandra Dasgupta
Life of this patent
Estimating the term…
Abstract
The present invention relates to an anti arrhythmic pharmaceutical comprising effective amount of compound designated as KCV-CAF obtained from the venom of Indian snake King Cobra Ophiophagus hannah and optionally pharmaceutically acceptable ingredients and a process of isolating the said compound KCV-CAF from the venom of the Indian snake King Cobra (Ophiophagus hannah).
Claims13
An antiarrythmic compound designated as KCV-CAF obtained from the venom of Indian snake King Cobra Ophiophagus hannah.
An anti-arrhythmic pharmaceutical composition comprising effective amount of compound designated as KCV-CAF obtained from the venom of Indian snake king cobra Ophiophagus hannah, mixed optionally with one or more pharmaceutically acceptable ingredients.
Process for the isolation of a anti-arrhythmic compound designated as KCV-CAF useful for pharmacological purposes, said process comprising steps of:
- i. obtaining venom of snake king cobra;
- and
- ii. purifying the venom of step (a) by repeated chromatographic methods to obtain the novel anti-arrhythmic compound KCV-CAF.
Dependencies are inferred from the claim text.